- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Generating Anti-TIGIT and CD155 Monoclonal Antibodies for Tumor Immunotherapy ; volume:04 ; number:03 ; year:2022 ; pages:e197-e206
Pharmaceutical fronts ; 04, Heft 03 (2022), e197-e206
- Contributor
-
Duan, Yu-Hang
Bian, Yan-lin
Zhu, Jian-Wei
- DOI
-
10.1055/s-0042-1755454
- URN
-
urn:nbn:de:101:1-2022120111450188422056
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Duan, Yu-Hang
- Bian, Yan-lin
- Zhu, Jian-Wei
Other Objects (12)
Establishment of anti-mesothelioma monoclonal antibodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
Establishment of anti-mesothelioma monoclonal antibodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
Establishment of anti-mesothelioma monoclonal antibodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease